S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.15 (+2.09%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.68 (+2.51%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.13 (+0.77%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.68 (+2.79%)
PRI   125.80 (+0.00%)
BAC   31.43 (+0.74%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.15 (+2.09%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.68 (+2.51%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.13 (+0.77%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.68 (+2.79%)
PRI   125.80 (+0.00%)
BAC   31.43 (+0.74%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
Log in

MiMedx Group Stock Price, News & Analysis (OTCMKTS:MDXG)

$3.66
-1.42 (-27.95 %)
(As of 10/23/2019 04:00 PM ET)
Today's Range
$3.66
Now: $3.66
$3.66
50-Day Range
$3.66
MA: $4.82
$5.41
52-Week Range
$0.95
Now: $3.66
$6.59
VolumeN/A
Average Volume137,501 shs
Market Capitalization$406.41 million
P/E RatioN/A
Dividend YieldN/A
Beta0.78
MiMedx Group, Inc, a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts. The company's proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:MDXG
CUSIPN/A
Phone770-651-9100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$245.01 million
Cash Flow$0.13 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$406.41 million
Next Earnings DateN/A
OptionableOptionable

Receive MDXG News and Ratings via Email

Sign-up to receive the latest news and ratings for MDXG and its competitors with MarketBeat's FREE daily newsletter.


MiMedx Group (OTCMKTS:MDXG) Frequently Asked Questions

What is MiMedx Group's stock symbol?

MiMedx Group trades on the OTCMKTS under the ticker symbol "MDXG."

How will MiMedx Group's stock buyback program work?

MiMedx Group declared that its board has approved a share repurchase program on Wednesday, December 13th 2017, which permits the company to repurchase $10,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's board of directors believes its stock is undervalued.

How were MiMedx Group's earnings last quarter?

MiMedx Group Inc (OTCMKTS:MDXG) released its quarterly earnings data on Thursday, October, 26th. The medical equipment provider reported $0.08 earnings per share (EPS) for the quarter, meeting the Thomson Reuters' consensus estimate of $0.08. The medical equipment provider had revenue of $84.60 million for the quarter, compared to analysts' expectations of $84.60 million. The business's revenue was up 31.4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.06 EPS. View MiMedx Group's Earnings History.

Has MiMedx Group been receiving favorable news coverage?

Media stories about MDXG stock have trended somewhat positive this week, according to InfoTrie. The research firm rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. MiMedx Group earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned media stories about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for MiMedx Group.

Who are some of MiMedx Group's key competitors?

What other stocks do shareholders of MiMedx Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MiMedx Group investors own include Hawkins (HWKN), Micron Technology (MU), CA (CA), Endologix (ELGX), Gilead Sciences (GILD), Opko Health (OPK), Allergan (AGN), Alibaba Group (BABA), Nuance Communications (NUAN) and Synergy Pharmaceuticals (SGYP).

Who are MiMedx Group's key executives?

MiMedx Group's management team includes the folowing people:
  • Ms. Alexandra O. Haden, Gen. Counsel and Sec. (Age 43)
  • Mr. David J. Coles, Interim Chief Exec. Officer (Age 53)
  • Mr. Edward J. Borkowski, Interim Chief Financial Officer (Age 60)
  • Dr. Thomas J. Koob, Chief Scientific Officer (Age 69)
  • Mr. Thornton A. Kuntz Jr., Sr. VP of Admin. (Age 64)

How do I buy shares of MiMedx Group?

Shares of MDXG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is MiMedx Group's stock price today?

One share of MDXG stock can currently be purchased for approximately $3.66.

How big of a company is MiMedx Group?

MiMedx Group has a market capitalization of $406.41 million and generates $245.01 million in revenue each year. View Additional Information About MiMedx Group.

What is MiMedx Group's official website?

The official website for MiMedx Group is http://www.mimedx.com/.

How can I contact MiMedx Group?

MiMedx Group's mailing address is 1775 W OAK COMMONS COURT NE, MARIETTA GA, 30062. The medical equipment provider can be reached via phone at 770-651-9100 or via email at [email protected]


MarketBeat Community Rating for MiMedx Group (OTCMKTS MDXG)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  399 (Vote Outperform)
Underperform Votes:  272 (Vote Underperform)
Total Votes:  671
MarketBeat's community ratings are surveys of what our community members think about MiMedx Group and other stocks. Vote "Outperform" if you believe MDXG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDXG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel